Welcome to the e-CCO Library!

P0582: Do we need a Structured Transition Programme for patients with IBD? The Irish Experience
Year: 2025
Source: ECCO'25
Authors: Dohertyx7x7x7 J.(1x7x7x72);Hurleyx7x7x7 C.(3)*;Girodx7x7x7 P.(4);Peacockx7x7x7 J.(5);Stallardx7x7x7 L.(2);Quinnx7x7x7 S.(2);Broderickx7x7x7 A.(2);Stenkex7x7x7 E.(2);Husseyx7x7x7 S.(2);Harteryx7x7x7 K.(1);Kevansx7x7x7 D.(1);O Donnellx7x7x7 S.(6);Slatteryx7x7x7 E.(5);Cullenx7x7x7 G.(4);Dohertyx7x7x7 G.(7);Murphyx7x7x7 C.(3);Bourkex7x7x7 B.(2);Dunnex7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0583: The Effects of a Dual-Strain Probiotic Versus Placebo on Cytokine Levels in Patients with Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Carrollx7x7x7 A.(1)*;Meagherx7x7x7 S.(1);Walkerx7x7x7 C.(1);Magdeldinx7x7x7 H.(1);McNamarax7x7x7 D.(1);Ryanx7x7x7 B.(1);O'Donnellx7x7x7 S.(1);Breslinx7x7x7 N.(1);Corrx7x7x7 S.(2);O'Connorx7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0584: Rituximab versus infliximab for the treatment of PR3-ANCA Positive Moderately to Severely Active Ulcerative Colotis: A retrospective Multicentre Real-World Study
Year: 2025
Source: ECCO'25
Authors: Yux7x7x7 Q.(1)*;Yiyux7x7x7 C.(1);Yidongx7x7x7 C.(1);Zhux7x7x7 L.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0585: A treat to target approach in IBD: contemporary real-world perspectives from an international survey
Year: 2025
Source: ECCO'25
Authors: Sharipx7x7x7 M.T.(1)*;Brezinax7x7x7 B.(1);La Revilla Negrox7x7x7 J.(1);Subramanianx7x7x7 S.(1);Parkesx7x7x7 M.(1);Rainex7x7x7 T.(1);Noorx7x7x7 N.M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0586: Nationwide population-based cohort study on the use and persistence of infliximab (IV and SC) in France: the Riposte IBD study
Year: 2025
Source: ECCO'25
Authors: Kirchgesnerx7x7x7 J.(1)*;Quilesx7x7x7 N.(2);Foulleyx7x7x7 L.(3);Habauzitx7x7x7 C.(3);Benkhalifax7x7x7 S.(3);Pratix7x7x7 C.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0587: Effectiveness and safety of Risankizumab in Crohn’s disease patients from a large Italian cohort: preliminary results from the RESOLVE IgIBD study
Year: 2025
Source: ECCO'25
Authors: Scaldaferrix7x7x7 F.(1);Di Vincenzox7x7x7 F.(2)*;Alloccax7x7x7 M.(3);Aloix7x7x7 M.(4);Balestrierix7x7x7 P.(5);Bertanix7x7x7 L.(6);Bezziox7x7x7 C.(7);Bodinix7x7x7 C.(8);Calabresex7x7x7 E.(9);Capriolix7x7x7 F.(10);Cicalax7x7x7 M.(11);Danesex7x7x7 S.(12);Del Zannax7x7x7 E.(13);Fantinix7x7x7 M.C.(14);Festax7x7x7 S.(15);Fiorinox7x7x7 G.(16);Furfarox7x7x7 F.(17);Gabbiadinix7x7x7 R.(18);Geccherlex7x7x7 A.(19);Laterzax7x7x7 L.(20);Marzox7x7x7 M.(21);Mastronardix7x7x7 M.(22);Moccix7x7x7 G.(23);Monterubbianesix7x7x7 R.(24);Onalix7x7x7 S.(25);Onidix7x7x7 F.M.(23);Picax7x7x7 R.(26);Principix7x7x7 M.(27);Pugliesex7x7x7 D.(28);Savarinox7x7x7 E.(29);Tursix7x7x7 A.(30);Variolax7x7x7 A.(31);Armuzzix7x7x7 A.(32);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0588: Efficacy and health-related quality of life associated with second-line vedolizumab after one prior first-line anti-tumour necrosis factor treatment in patients with active ulcerative colitis: A meta-analysis of the GEMINI-1 and VISIBLE-1 trials
Year: 2025
Source: ECCO'25
Authors: Atreyax7x7x7 R.(1)*;Kirchgesnerx7x7x7 J.(2);Cheahx7x7x7 Z.(3);Biedermannx7x7x7 P.(4);Bakkerx7x7x7 L.(5);Meyerx7x7x7 M.(6);Rainex7x7x7 T.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0589: High treatment persistence following infliximab dose escalation in Inflammatory Bowel Disease: A real world study
Year: 2025
Source: ECCO'25
Authors: Salehix7x7x7 O.(1)*;Gondalx7x7x7 F.(1);Terlatox7x7x7 M.(1);Pillayx7x7x7 L.(1);Segalx7x7x7 J.P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P058: Bacterial activation of thioguanine results in lymphocyte independent improvement in murine colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Oancea1, 2, I. Das1, D. Aguirre de Cárcer3, R. Movva1, 4, V. Schreiber1, Y. Yang1, 5, M. Proctor1, R. Wang1, Y. Sheng1, M. Lobb1, P. Ó Cuiv6, J. A. Duley1, 4, J. Begun*2, 7, T. H. J. Florin1, 2

Created: Friday, 22 February 2019, 9:49 AM
P058: Comparison of Calprotectin levels in stool and rectal mucus in subjects with suspected or confirmed inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

McLaughlin J.*1, Hedley A.D.2, Treasure P.3, Collins C.M.2, Craven R.A.2

Created: Wednesday, 20 February 2019, 10:36 AM
P058: Do circulating exosomes interfere with vedolizumab efficacy in IBD patients?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Domenis1, A. Cifu'1, M. Fabris1,2, G. Scardino3, M. Zilli3, M. Marino*3, F. Curcio1,2

Created: Friday, 22 February 2019, 9:41 AM
P058: IL-36 signaling in Crohn’s disease – characterization of a patient with an IL36RA mutation
Year: 2022
Source: ECCO'22
Authors: Hecker, J.(1);Letizia, M.(1);Loescher, B.S.(2);Franke, A.(2);Weidinger, C.(1);Siegmund, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P058: Immunological effects of hepatitis B virus vaccination in inflammatory bowel disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Soleto, I.(1)*;C. Marin, A.(1);Mora, I.(1);Villagrasa, J.R.(2);Baldan-Martin, M.(1);Ramírez, C.(1);Bernardo, D.(3);Chaparro, M.(1);P. Gisbert, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P058: Phosphodiesterase 8A domains at the site of leucocyte–endothelial cell adhesion in ulcerative colitis submucosa
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Ovadóttir1,2,3*, K. Danielsen3, K. Nielsen4, P. Epstein5, S. Brocke6, M. Kaminski2, A. Vang2,3,6

Created: Thursday, 21 February 2019, 9:14 AM
P058: Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Park, J.(1);Daeun , J.(2);Youn Wook , C.(2);Jae Hee , C.(1);Ji-Hwan , R.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P059 Cytokine responsive transcriptional networks in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Treveil1,2, P. Pavlidis3, A. Tsakmaki4, G. Bewick4, T. Korcsmaros1,2, N. Powell3,4,5

Created: Thursday, 30 January 2020, 10:12 AM
P0590: Long term outcomes of biologic therapy for the treatment of prepouch ileitis: a multi-centre multi-national retrospective study
Year: 2025
Source: ECCO'25
Authors: Ghersinx7x7x7 I.(1)*;Calinix7x7x7 G.(2);Koifmanx7x7x7 E.(3);Segalx7x7x7 J.(4);Argyrioux7x7x7 O.(5);McLaughlinx7x7x7 S.(6);Johnsonx7x7x7 H.(6);Rottolix7x7x7 M.(2);Sahnanx7x7x7 K.(5);Warusavitarnex7x7x7 J.(5);Hartx7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0591: Janus Kinase Inhibitors Improve Liver Biochemistry in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: an ECCO CONFER Study.
Year: 2025
Source: ECCO'25
Authors: Sorianox7x7x7 A.(1)*;Maggi x7x7x7 D.(2);Kagramanovax7x7x7 A.(3);Molnarx7x7x7 T.(4);Halaszx7x7x7 R.(4);Desmedtx7x7x7 V.(5);Holvoetx7x7x7 T.(5);Savarinox7x7x7 E.V.(6);Barberiox7x7x7 B.(6);Juilleratx7x7x7 P.(7);Vieujeanx7x7x7 S.(8);Zelinkovax7x7x7 Z.(9);Durikovax7x7x7 D.(10);Kubíčkováx7x7x7 K.(10);Avni Bironx7x7x7 I.(11);Aratari x7x7x7 A.(2);Bezziox7x7x7 C.(12);Bettenworthx7x7x7 D.(13);Cliffordx7x7x7 C.(14);Desiderix7x7x7 F.(15);Felicex7x7x7 C.(16);Levartovskyx7x7x7 A.(17);Melottix7x7x7 L.(18);Pugliesex7x7x7 D.(19);Scaldaferrix7x7x7 F.(20);Viganòx7x7x7 C.(21);Schnoyx7x7x7 E.(22);Teichx7x7x7 N.(23);Shouvalx7x7x7 D.(24);Drobnex7x7x7 D.(25);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0592: Safety of the Adjuvant Recombinant Herpes Zoster Vaccine in Crohn’s Disease and Ulcerative Colitis: A Real-World Study
Year: 2025
Source: ECCO'25
Authors: Kimx7x7x7 D.H.(1)*;Parkx7x7x7 Y.H.(2);Kangx7x7x7 S.B.(3);Kimx7x7x7 K.O.(4);Parkx7x7x7 S.H.(5);Leex7x7x7 Y.J.(6);Leex7x7x7 J.(7);Moonx7x7x7 W.(8);Parkx7x7x7 S.J.(9);Nax7x7x7 S.Y.(10);Kimx7x7x7 E.S.(11);Oh x7x7x7 S.J.(12);Shinx7x7x7 S.Y.(13);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0593: High-dose Tofacitinib in Acute Severe Ulcerative Colitis: an option to avoid colectomy?
Year: 2025
Source: ECCO'25
Authors: Sierra Ausínx7x7x7 M.(1)*;Latras Cortésx7x7x7 I.(1);Suárez Álvarezx7x7x7 P.(1);Cano Sanzx7x7x7 N.(1);Elosua Gonzálezx7x7x7 T.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session